Form4insider filings, from the source

SEC Form 4 · accession 0000921895-17-000501

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Matthew D Perry
Director · Other
Period of report
Feb 23, 2017
Accepted (ET)
Feb 27, 2017 · 7:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1holding———8,403D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F1,F4$4.25Feb 23, 2017A50,000A—Feb 22, 2027Common Stock50,00050,000D
Restricted Stock UnitsF1,F3,F2—holding—————Common Stock34,73634,736D

Explanation of responses